ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · IEX Real-Time Price · USD
65.62
+0.14 (0.21%)
At close: Apr 22, 2024, 4:00 PM
65.15
-0.47 (-0.72%)
After-hours: Apr 22, 2024, 7:38 PM EDT
ANI Pharmaceuticals Market Cap
ANI Pharmaceuticals has a market cap or net worth of $1.38 billion as of April 22, 2024. Its market cap has increased by 101.98% in one year.
Market Cap
1.38B
Enterprise Value
1.44B
1-Year Change
101.98%
Ranking
Category
Stock Price
$65.62
Market Cap Chart
Since May 5, 2000, ANI Pharmaceuticals's market cap has increased from $31.10M to $1.38B, an increase of 4,326.78%. That is a compound annual growth rate of 17.13%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 19, 2024 | 1.38B | 1.40% |
Apr 18, 2024 | 1.36B | -1.38% |
Apr 17, 2024 | 1.38B | -0.12% |
Apr 16, 2024 | 1.38B | -1.12% |
Apr 15, 2024 | 1.40B | -0.87% |
Apr 12, 2024 | 1.41B | -1.80% |
Apr 11, 2024 | 1.44B | 1.72% |
Apr 10, 2024 | 1.41B | -0.13% |
Apr 9, 2024 | 1.41B | -0.80% |
Apr 8, 2024 | 1.42B | -0.09% |
Apr 5, 2024 | 1.43B | -0.43% |
Apr 4, 2024 | 1.43B | 1.04% |
Apr 3, 2024 | 1.42B | 0.78% |
Apr 2, 2024 | 1.41B | -1.69% |
Apr 1, 2024 | 1.43B | -1.83% |
Mar 28, 2024 | 1.46B | -0.80% |
Mar 27, 2024 | 1.47B | 0.20% |
Mar 26, 2024 | 1.47B | -0.07% |
Mar 25, 2024 | 1.47B | 0.03% |
Mar 22, 2024 | 1.47B | 0.38% |
Mar 21, 2024 | 1.46B | 1.71% |
Mar 20, 2024 | 1.44B | 0.43% |
Mar 19, 2024 | 1.43B | 0.36% |
Mar 18, 2024 | 1.43B | 2.46% |
Mar 15, 2024 | 1.39B | -0.08% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Edgewise Therapeutics | 1.42B |
LeMaitre Vascular | 1.41B |
Morphic Holding | 1.40B |
National HealthCare | 1.39B |
Zai Lab | 1.39B |
Agiliti | 1.37B |
Tilray Brands | 1.34B |
Kura Oncology | 1.33B |